Dual diagnosis treatment for Wellington — one team, both diagnoses, together.

Wellington sits 28 miles west of RECO's Delray Beach campus — a 38-minute drive that makes daily commuting through detox or early PHP impractical for most clients. RECO's dual diagnosis model consolidates MAT, psychotropic prescribing, and trauma therapy under one in-house addiction psychiatrist, eliminating the fragmented-prescribing relapse pathway most commonly seen on readmission. For Olympia, Versailles, and Palm Beach Polo families, care typically pairs on-campus PHP or IOP with a stay in RECO's sober-living network.

Wellington sits 28 miles west of RECO Health’s Delray Beach campus — about 38 minutes by car when Southern Boulevard and I-95 cooperate. That distance matters clinically: for clients from Olympia, Versailles, Aero Club, Palm Beach Polo, and Wellington View, a daily commute during detox or the first weeks of partial hospitalization is rarely sustainable, so most Wellington admissions to RECO’s dual diagnosis treatment program combine on-campus care with a stay in the affiliated sober-living network, then transition home once psychiatric and substance-use stability both hold.

Why sequential treatment fails for co-occurring disorders

The clinical literature on co-occurring substance use and psychiatric illness is unambiguous. Sequential treatment — the idea that a client should “get sober first, then we’ll address the mental health” — produces worse outcomes across every meaningful metric: relapse rates, psychiatric hospitalization, engagement in aftercare, and one-year sustained sobriety. SAMHSA and NIDA endorsed integrated dual disorder treatment as the standard of care in the 1990s, yet many programs still operate a serial model because it is easier to staff.

The mechanism of failure is mechanical. An untreated psychiatric diagnosis destabilizes the treated addiction, and vice versa. Untreated major depression during residential care drives anhedonia, low motivation, and early against-medical-advice discharge; active drinking blocks the therapeutic effect of an SSRI like sertraline or escitalopram, so the depression looks pharmacologically refractory when it is simply undertreated. Integration requires clinicians credentialed in both addiction medicine and psychiatric care working from a single treatment plan — not a referral chain between two separate teams.

The high-prevalence co-occurring diagnoses

Five psychiatric conditions account for the majority of dual diagnosis presentations at RECO: major depressive disorder, PTSD, generalized anxiety disorder, bipolar disorder, and adult ADHD. All five are screened at intake with validated instruments — the PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum, and ASRS for ADHD — alongside CIWA or COWS for withdrawal severity and the six ASAM Criteria dimensions for level-of-care determination.

Each diagnosis has a defined evidence-based pathway. Depression is treated with an SSRI or SNRI paired with CBT and behavioral activation, with rTMS or ketamine reserved for treatment-resistant presentations. PTSD moves through cognitive processing therapy, prolonged exposure, or EMDR once stabilization allows exposure work. Bipolar disorder is managed with mood stabilizer optimization — lithium, lamotrigine, valproate — or an atypical like aripiprazole or quetiapine when needed. ADHD is treated with a non-stimulant first line (atomoxetine, bupropion) or a carefully monitored stimulant when the addiction history permits. Borderline personality features that are commonly misclassified as bipolar are addressed with DBT skills training rather than an escalating medication regimen.

MAT and psychotropic medication managed by one psychiatrist

Buprenorphine or extended-release naltrexone for opioid use disorder, oral naltrexone or acamprosate for alcohol use disorder, and the client’s antidepressant, mood stabilizer, or ADHD medication are all managed by the same in-house addiction psychiatrist. Interactions are considered on one chart, contraindications are flagged at the point of prescribing, and dose changes are coordinated across the full regimen rather than negotiated between two outside providers who rarely speak.

Fragmented prescribing is one of the most common relapse pathways we see on readmission. A primary care doctor manages the SSRI, an outside psychiatrist manages a benzodiazepine for anxiety, an MAT clinic manages buprenorphine, and no one is watching the whole picture — the benzodiazepine sabotages the buprenorphine stabilization, the SSRI never gets titrated because no one owns it, and the client relapses within weeks of discharge. Consolidating prescribing under one psychiatrist eliminates that failure mode. Where clinically indicated, RECO’s psychiatry service also offers rTMS (typically 3,000 pulses per session at 120% of motor threshold, five days a week for six weeks) for treatment-resistant depression and IV ketamine or intranasal esketamine for select refractory cases with concurrent addiction.

Trauma is often the through-line

For a substantial share of dual diagnosis clients, unprocessed trauma is upstream of both the substance use and the mood disorder. The substances are functioning as an autonomic regulator — quieting hyperarousal, blunting intrusive imagery, allowing sleep — and the depression is the downstream cost of chronic dysregulation. Treating either symptom in isolation, without addressing the trauma driving both, reliably produces short-term gains that fail within six months.

RECO’s trauma protocol follows the stabilization-first sequence the trauma treatment literature has converged on. Phase one establishes physiological and environmental safety: detox is complete, sleep is regularized, and the client has a functional set of grounding and distress-tolerance skills drawn from DBT and ACT. Phase two moves into evidence-based processing — cognitive processing therapy, prolonged exposure, or EMDR — once the client’s window of tolerance can hold it. Attempting exposure work before stabilization reliably destabilizes and is a common reason clients leave lower-quality programs against medical advice.

What to expect on your first visit

Intake begins with a comprehensive biopsychosocial assessment organized around the six ASAM Criteria dimensions: acute intoxication and withdrawal risk, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment. Withdrawal severity is scored with CIWA for alcohol or COWS for opioids, and the psychiatric screens — PHQ-9, GAD-7, PCL-5, MDQ, ASRS, and YBOCS where OCD is suspected — run the same day so the treatment plan is built from real data rather than a self-reported summary.

A psychiatric evaluation with an in-house addiction psychiatrist is scheduled within 24 to 72 hours of admission — sooner when acuity requires it. Medication reconciliation happens the same day the client arrives: existing prescriptions are reviewed for interactions with any MAT, appropriateness in early recovery is assessed, and a coordinated regimen is put in writing. Family contact, when the client authorizes it under 42 CFR Part 2, typically begins in the first week, with a formal family session scheduled by the second or third week.

Insurance and admissions from Wellington

RECO Health is in-network with Florida Blue, BCBS, Aetna, Cigna, UnitedHealthcare, and Humana, which covers the majority of commercial plans carried by Wellington residents. Verification of benefits is completed before admission so the client and family know deductible, coinsurance, and out-of-pocket responsibility for each level of care — detox, residential, PHP, IOP — in writing rather than at discharge. For dual diagnosis specifically, the substance use and psychiatric components of care are typically billed under the same behavioral health benefit, so coverage is not split between two carriers.

Admissions coordinates transport from Wellington directly — from the Palm Beach Polo corridor, Wellington View, or anywhere else in the 33414 and 33449 ZIP codes — because self-driving to detox is neither safe nor clinically appropriate at the point of admission. Once the client has transitioned to IOP, some Wellington clients commute the 38 minutes daily; others remain in RECO’s sober-living network until returning home makes clinical sense.

Serving residents of: Olympia, Versailles, Aero Club, Palm Beach Polo, Wellington View.